Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target

Incyte outlined a strategy to diversify beyond JAKAFI by expanding its non-JAKAFI business and advancing a broader late-stage pipeline. Management is preparing for JAKAFI's expected loss of exclusivity after 2029, signaling a proactive but longer-term effort to offset a key product concentration risk.